Oracle and M42 Partner to Advance Personalized Healthcare in UAE
Oracle Corporation has entered into a strategic collaboration with M42, a global health leader specializing in technology, artificial intelligence, and genomics, to transform healthcare delivery across the UAE. The partnership will leverage AI, advanced analytics, and genomic data from the Emirati Genome Program to drive proactive healthcare, promote healthy longevity, and enable precision medicine at scale. By integrating this genomic data into Oracle Health's electronic health record system, the initiative aims to provide pharmacogenomic recommendations at the point of care, supporting personalized and data-driven treatment decisions. The collaboration will also deliver nationwide access to a secure, scalable patient portal, enhancing care coordination and patient engagement throughout the UAE.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oracle Corporation published the original content used to generate this news brief on November 03, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.